|
1
|
Paderno A, Morello R and Piazza C: Tongue
carcinoma in young adults: A review of the literature. Acta
Otorhinolaryngol Ital. 38:175–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mannelli G, Arcuri F, Agostini T,
Innocenti M, Raffaini M and Spinelli G: Classification of tongue
cancer resection and treatment algorithm. J Surg Oncol.
117:1092–1099. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun L, Liang J, Wang Q, Li Z, Du Y and Xu
X: MicroRNA-137 suppresses tongue squamous carcinoma cell
proliferation, migration and invasion. Cell Prolif. 49:628–635.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Semsettin B, Sinan E and Nigar V:
Comparison of the effects of topical cyclosporine a 0.05%,
cyclosporine a 2%, epinastine hydrochloride 0.05%, and prednisolone
acetate 1% on allergic inflammation in an experimental allergic
conjunctivitis model. Cornea. 32:1465–1469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bello IO, Soini Y and Salo T: Prognostic
evaluation of oral tongue cancer: Means, markers and perspectives
(II). Oral Oncol. 46:636–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahmadi N, Chan M, Huo YR, Sritharan N and
Chin RY: Survival outcome of tonsillar squamous cell carcinoma
(TSCC) in the context of human papillomavirus (HPV): A systematic
review and meta-analysis. Surgeon. 17:6–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramqvist T, Grün N and Dalianis T: Human
papillomavirus and tonsillar and base of tongue cancer. Viruses.
7:1332–1343. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lozev I, Ruseva S, Pidakev I, Cardoso JC,
Wollina U, Lotti T, Maximov GK, Terziev I and Tchernev G:
Mucoepidermoid carcinoma (MEC) of parotid gland with massive
cutaneous involvement: Bilateral pedicle advancement flap
(U-Plasty) as adequate surgical approach. Open Access Maced J Med
Sci. 6:134–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu L, Wang Y, Li R, Liu A, Zhang X, Zuo C
and Xu X: Surgical treatment of early tongue squamous cell
carcinoma and patient survival. Oncol Lett. 17:5681–5685.
2019.PubMed/NCBI
|
|
10
|
Ng JH, Iyer NG, Tan MH and Edgren G:
Changing epidemiology of oral squamous cell carcinoma of the
tongue: A global study. Head Neck. 39:297–304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wade MH and Plotnick H: Xeroderma
pigmentosum and squamous cell carcinoma of the tongue.
Identification of two black patients as members of complementation
group C. J Am Acad Dermatol. 12:515–521. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang P, Zhang L, Liu H, Zhao L, Li Y,
Shen JX, Liu Q, Liu MZ and Xi M: Clinicopathologic characteristics
and prognosis of tongue squamous cell carcinoma in patients with
and without a history of radiation for nasopharyngeal carcinoma: A
matched case-control study. Cancer Res Treat. 49:695–705. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Velly AM, Franco EL, Schlecht N, Pintos J,
Kowalski LP, Oliveira BV and Curado MP: Relationship between dental
factors and risk of upper aerodigestive tract cancer. Oral Oncol.
34:284–291. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Troiano G, Rubini C, Togni L, Caponio VC,
Zhurakivska K, Santarelli A, Cirillo N, Lo Muzio L and Mascitti M:
The immune phenotype of tongue squamous cell carcinoma predicts
early relapse and poor prognosis. Cancer Med. 9:8333–8344. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hussein AA, Forouzanfar T, Bloemena E, de
Visscher J, Brakenhoff RH, Leemans CR and Helder MN: A review of
the most promising biomarkers for early diagnosis and prognosis
prediction of tongue squamous cell carcinoma. Br J Cancer.
119:724–736. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamura K, Akiba J, Ogasawara S, Naito Y,
Nakayama M, Abe Y, Kusukawa J and Yano H: SUOX is negatively
associated with multistep carcinogenesis and proliferation in oral
squamous cell carcinoma. Med Mol Morphol. 51:102–110. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng G, Zhang Z, Liu H, Xiong Y, Luo L,
Jia X, Peng C, Zhang Q, Li N, Gu Y, et al: HSP27-mediated
extracellular and intracellular signaling pathways synergistically
confer chemoresistance in squamous cell carcinoma of tongue. Clin
Cancer Res. 24:1163–1175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen H and Dai J: miR-409-3p suppresses
the proliferation, invasion and migration of tongue squamous cell
carcinoma via targeting RDX. Oncol Lett. 16:543–551.
2018.PubMed/NCBI
|
|
19
|
Solomon B, Young RJ and Rischin D: Head
and neck squamous cell carcinoma: Genomics and emerging biomarkers
for immunomodulatory cancer treatments. Semin Cancer Biol.
52:228–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Falzone L, Lupo G, La Rosa G, Crimi S,
Anfuso CD, Salemi R, Rapisarda E, Libra M and Candido S:
Identification of novel MicroRNAs and their diagnostic and
prognostic significance in oral cancer. Cancers (Basel).
11:6102019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu M, Wu G, Chen Y, Wang H, Gao Y and Wang
A: Bioinformatic screening and experimental analysis identify SFRP1
as a prognostic biomarker for tongue squamous cell carcinomas. Arch
Oral Biol. 110:1045872020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang R, Zhou X, Wang H, Zhou B, Dong S,
Ding Q, Peng M, Sheng X, Yao J, Huang R, et al: Integrative
analysis of gene expression profiles reveals distinct molecular
characteristics in oral tongue squamous cell carcinoma. Oncol Lett.
17:2377–2387. 2019.PubMed/NCBI
|
|
23
|
Usami Y, Ishida K, Sato S, Kishino M,
Kiryu M, Ogawa Y, Okura M, Fukuda Y and Toyosawa S: Intercellular
adhesion molecule-1 (ICAM-1) expression correlates with oral cancer
progression and induces macrophage/cancer cell adhesion. Int J
Cancer. 133:568–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang D, Chen ZG, Liu SH, Dong ZQ, Dalin
M, Bao SS, Hu YW and Wei FC: Galectin-3 gene silencing inhibits
migration and invasion of human tongue cancer cells in vitro via
downregulating β-catenin. Acta Pharmacol Sin. 34:176–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Liu X, Chen Z, Huang H, Jin Y,
Kolokythas A, Wang A, Dai Y, Wong DT and Zhou X: Polycomb group
protein EZH2-mediated E-cadherin repression promotes metastasis of
oral tongue squamous cell carcinoma. Mol Carcinog. 52:229–236.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Candido S, Lupo G, Pennisi M, Basile MS,
Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra
M and Falzone L: The analysis of miRNA expression profiling
datasets reveals inverse microRNA patterns in glioblastoma and
Alzheimer's disease. Oncol Rep. 42:911–922. 2019.PubMed/NCBI
|
|
27
|
Falzone L, Romano GL, Salemi R, Bucolo C,
Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido
S: Prognostic significance of deregulated microRNAs in uveal
melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI
|
|
28
|
Falzone L, Scola L, Zanghì A, Biondi A, Di
Cataldo A, Libra M and Candido S: Integrated analysis of colorectal
cancer microRNA datasets: Identification of microRNAs associated
with tumor development. Aging (Albany NY). 10:1000–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hafsi S, Candido S, Maestro R, Falzone L,
Soua Z, Bonavida B, Spandidos DA and Libra M: Correlation between
the overexpression of Yin Yang 1 and the expression levels of
miRNAs in Burkitt's lymphoma: A computational study. Oncol Lett.
11:1021–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li R, Faden DL, Fakhry C, Langelier C,
Jiao Y, Wang Y, Wilkerson MD, Pedamallu CS, Old M, Lang J, et al:
Clinical, genomic, and metagenomic characterization of oral tongue
squamous cell carcinoma in patients who do not smoke. Head Neck.
37:1642–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li B, Li CH, Guo H, Chen J and Wang SX:
Analysis of 27 cases of defect restoration using infrahyoid
myocutaneous flap after intraoral cancer surgery. Zhonghua Er Bi
Yan Hou Tou Jing Wai Ke Za Zhi. 43:826–829. 2008.(In Chinese).
PubMed/NCBI
|
|
33
|
Liu X, Qiao B, Zhao T, Hu F, Lam AK and
Tao Q: Sox2 promotes tumor aggressiveness and
epithelial-mesenchymal transition in tongue squamous cell
carcinoma. Int J Mol Med. 42:1418–1426. 2018.PubMed/NCBI
|
|
34
|
Tang Q, Cheng B, Xie M, Chen Y, Zhao J,
Zhou X and Chen L: Circadian clock gene bmal1 inhibits
tumorigenesis and increases paclitaxel sensitivity in tongue
squamous cell carcinoma. Cancer Res. 77:532–544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka Y, Araki K, Tanaka S, Miyagawa Y,
Suzuki H, Kamide D, Tomifuji M, Uno K, Kimura E, Yamashita T, et
al: Sentinel lymph node-targeted therapy by oncolytic sendai virus
suppresses micrometastasis of head and neck squamous cell carcinoma
in an orthotopic nude mouse model. Mol Cancer Ther. 18:1430–1438.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong J, Feng J, Qiu L, Gao Z, Li P, Pang
L and Zhang Z: SDF-1-loaded PLGA nanoparticles for the targeted
photoacoustic imaging and photothermal therapy of metastatic lymph
nodes in tongue squamous cell carcinoma. Int J Pharm. 554:93–104.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McCubrey JA, Lertpiriyapong K, Steelman
LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM,
Cocco L, et al: Effects of resveratrol, curcumin, berberine and
other nutraceuticals on aging, cancer development, cancer stem
cells and microRNAs. Aging (Albany NY). 9:1477–1536. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu Y, Meng LB, Di CY, Huo YH, Yao BC,
Zhang TJ and Hua Z: Exploration of the differentially expressed
long noncoding RNAs and genes of morphine tolerance via
bioinformatic analysis. J Comput Biol. 26:1379–1393. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zou YF, Meng LB, Wang QQ, He ZK, Hu CH,
Shan MJ, Wang DY and Yu X: Identification and functional enrichment
analysis of potential diagnostic and therapeutic targets in
adamantinomatous craniopharyngioma. J Comput Biol. 27:55–68. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Liu J, Fu X and Yang A:
Identification of key genes and pathways in tongue squamous cell
carcinoma using bioinformatics analysis. Med Sci Monit.
23:5924–5932. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li T, Wu Q, Liu D and Wang X: miR-27b
suppresses tongue squamous cell carcinoma epithelial-mesenchymal
transition by targeting ITGA5. Onco Targets Ther. 13:11855–11867.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen Y, Guo Y and Yan W: lncRNA
RP5-916L7.2 correlates with advanced tumor stage, and promotes
cells proliferation while inhibits cells apoptosis through
targeting miR-328 and miR-939 in tongue squamous cell carcinoma.
Clin Biochem. 67:24–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Meng LB, Shan MJ, Qiu Y, Qi R, Yu ZM, Guo
P, Di CY and Gong T: TPM2 as a potential predictive biomarker for
atherosclerosis. Aging (Albany NY). 11:6960–6982. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y, Du W, Chen Z and Xiang C:
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and
facilitates immune escape in lung adenocarcinoma. Exp Cell Res.
359:449–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kramerova I, Kumagai-Cresse C, Ermolova N,
Mokhonova E, Marinov M, Capote J, Becerra D, Quattrocelli M,
Crosbie RH, Welch E, et al: Spp1 (osteopontin) promotes TGFβ
processing in fibroblasts of dystrophin-deficient muscles through
matrix metalloproteinases. Hum Mol Genet. 28:3431–3442. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Morse C, Tabib T, Sembrat J, Buschur KL,
Bittar HT, Valenzi E, Jiang Y, Kass DJ, Gibson K, Chen W, et al:
Proliferating SPP1/MERTK-expressing macrophages in idiopathic
pulmonary fibrosis. Eur Respir J. 54:18024412019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guarneri C, Bevelacqua V, Polesel J,
Falzone L, Cannavò PS, Spandidos DA, Malaponte G and Libra M: NF-κB
inhibition is associated with OPN/MMP-9 downregulation in cutaneous
melanoma. Oncol Rep. 37:737–746. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shevde LA and Samant RS: Role of
osteopontin in the pathophysiology of cancer. Matrix Biol.
37:131–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li S, Yang R, Sun X, Miao S, Lu T, Wang Y,
Wo Y and Jiao W: Identification of SPP1 as a promising biomarker to
predict clinical outcome of lung adenocarcinoma individuals. Gene.
679:398–404. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Choe EK, Yi JW, Chai YJ and Park KJ:
Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to
poor survival outcomes in colorectal cancer. J Surg Oncol.
117:1833–1840. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu C, Sun L, Jiang C, Zhou H, Gu L, Liu Y
and Xu Q: SPP1, analyzed by bioinformatics methods, promotes the
metastasis in colorectal cancer by activating EMT pathway. Biomed
Pharmacother. 91:1167–1177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang HH, Wang XW and Tang CE: Osteopontin
expression in nasopharyngeal carcinoma: Its relevance to the
clinical stage of the disease. J Cancer Res Ther. 7:138–142. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ma R, Luo X, Feng S, Li J, Fan Y, Wen W
and Li H: Osteopontin promotes EZH2 expression and tumor
progression in nasopharyngeal carcinoma. ORL J Otorhinolaryngol
Relat Spec. 76:273–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang G, Peng X, Guo P and Yang G:
Association of osteopontin polymorphism with cancer risk: A
meta-analysis. Int J Clin Exp Med. 8:20911–20917. 2015.PubMed/NCBI
|
|
55
|
Zou B, Li J, Xu K, Liu JL, Yuan DY, Meng Z
and Zhang B: Identification of key candidate genes and pathways in
oral squamous cell carcinoma by integrated Bioinformatics analysis.
Exp Ther Med. 17:4089–4099. 2019.PubMed/NCBI
|
|
56
|
Zhang C, Man DP, Ma SM, Cao SW and Li DW:
Expressions and significances of CD147, OPN and MMP-2 in oral
squamous cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban.
43:683–686. 2012.(In Chinese). PubMed/NCBI
|
|
57
|
Ito T, Hashimoto Y, Tanaka E, Kan T,
Tsunoda S, Sato F, Higashiyama M, Okumura T and Shimada Y: An
inducible short-hairpin RNA vector against osteopontin reduces
metastatic potential of human esophageal squamous cell carcinoma in
vitro and in vivo. Clin Cancer Res. 12:1308–1316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hu Q, Peng J, Chen X, Li H, Song M, Cheng
B and Wu T: Obesity and genes related to lipid metabolism predict
poor survival in oral squamous cell carcinoma. Oral Oncol.
89:14–22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang X, Zhang L, Tan X, Lin Y, Han X,
Wang H, Ming H, Li Q, Liu K and Feng G: Systematic analysis of
genes involved in oral cancer metastasis to lymph nodes. Cell Mol
Biol Lett. 23:532018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
D'Addazio G, Artese L, Traini T, Rubini C,
Caputi S and Sinjari B: Immunohistochemical study of osteopontin in
oral squamous cell carcinoma allied to fractal dimension. J Biol
Regul Homeost Agents. 32:1033–1038. 2018.PubMed/NCBI
|
|
61
|
Huang CF, Yu GT, Wang WM, Liu B and Sun
ZJ: Prognostic and predictive values of SPP1, PAI and caveolin-1 in
patients with oral squamous cell carcinoma. Int J Clin Exp Pathol.
7:6032–6039. 2014.PubMed/NCBI
|
|
62
|
Wang Y, Su J, Wang Y, Fu D, Ideozu JE,
Geng H, Cui Q, Wang C, Chen R, Yu Y, et al: The interaction of YBX1
with G3BP1 promotes renal cell carcinoma cell metastasis via
YBX1/G3BP1-SPP1- NF-κB signaling axis. J Exp Clin Cancer Res.
38:3862019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Aota Y, An HS, Homandberg G, Thonar EJ,
Andersson GB, Pichika R and Masuda K: Differential effects of
fibronectin fragment on proteoglycan metabolism by intervertebral
disc cells: A comparison with articular chondrocytes. Spine (Phila
Pa 1976). 30:722–728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Beumer S, Heijnen HF, IJsseldijk MJ,
Orlando E, de Groot PG and Sixma JJ: Platelet adhesion to
fibronectin in flow: The importance of von Willebrand factor and
glycoprotein Ib. Blood. 86:3452–3460. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Filenius S, Tervo T and Virtanen I:
Production of fibronectin and tenascin isoforms and their role in
the adhesion of human immortalized corneal epithelial cells. Invest
Ophthalmol Vis Sci. 44:3317–3325. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Amary F, Perez-Casanova L, Ye H, Cottone
L, Strobl AC, Cool P, Miranda E, Berisha F, Aston W, Rocha M, et
al: Synovial chondromatosis and soft tissue chondroma: Extraosseous
cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol.
32:1762–1771. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Cai X, Liu C, Zhang TN, Zhu YW, Dong X and
Xue P: Down-regulation of FN1 inhibits colorectal carcinogenesis by
suppressing proliferation, migration, and invasion. J Cell Biochem.
119:4717–4728. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Morita Y, Hata K, Nakanishi M, Omata T,
Morita N, Yura Y, Nishimura R and Yoneda T: Cellular fibronectin 1
promotes VEGF-C expression, lymphangiogenesis and lymph node
metastasis associated with human oral squamous cell carcinoma. Clin
Exp Metastasis. 32:739–753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yen CY, Huang CY, Hou MF, Yang YH, Chang
CH, Huang HW, Chen CH and Chang HW: Evaluating the performance of
fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and
glycoprotein CD44 as the potential biomarkers of oral squamous cell
carcinoma (OSCC). Biomarkers. 18:63–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Suresh A, Vannan M, Kumaran D, Gümüs ZH,
Sivadas P, Murugaian EE, Kekatpure V, Iyer S, Thangaraj K and
Kuriakose MA: Resistance/response molecular signature for oral
tongue squamous cell carcinoma. Dis Markers. 32:51–64. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhang Z, Pan J, Li L, Wang Z, Xiao W and
Li N: Survey of risk factors contributed to lymphatic metastasis in
patients with oral tongue cancer by immunohistochemistry. J Oral
Pathol Med. 40:127–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Brinkhof B, Zhang B, Cui Z, Ye H and Wang
H: ALCAM (CD166) as a gene expression marker for human mesenchymal
stromal cell characterisation. Gene X. 5:1000312020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhan S, Li J, Wang T and Ge W:
Quantitative proteomics analysis of sporadic medullary thyroid
cancer reveals FN1 as a potential novel candidate prognostic
biomarker. Oncologist. 23:1415–1425. 2018. View Article : Google Scholar : PubMed/NCBI
|
